At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- NJIT Researcher Fortifies Virtual Reality Tech for Cancer Patient Emergencies.
- Join Us Today for Rutgers Health Policy and Advocacy Corps
- Rutgers-Newark Launches Institute on Improving Communities Through AI and Interdisciplinary Data Work.
- New Jersey Voters Say Finding Quality, Affordable Child Care Is Difficult and a Major Barrier for Working Parents.
Categories
- Community (2,385)
- Covid (993)
- CTO Events (6)
- News (3,023)
- Pilots (21)